Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Advertisement

Accepted for/Published in: JMIR mHealth and uHealth

Date Submitted: Jun 19, 2019
Open Peer Review Period: Jun 19, 2019 - Jun 27, 2019
Date Accepted: Feb 29, 2020
(closed for review but you can still tweet)

The final, peer-reviewed published version of this preprint can be found here:

Efficacy of a Mobile Texting App (HepTalk) in Encouraging Patient Participation in Viral Hepatitis B Care: Development and Cohort Study

Hyun C, McMenamin J, Ko O, Kim S

Efficacy of a Mobile Texting App (HepTalk) in Encouraging Patient Participation in Viral Hepatitis B Care: Development and Cohort Study

JMIR Mhealth Uhealth 2020;8(4):e15098

DOI: 10.2196/15098

PMID: 32234704

PMCID: 7160703

Warning: This is an author submission that is not peer-reviewed or edited. Preprints - unless they show as "accepted" - should not be relied on to guide clinical practice or health-related behavior and should not be reported in news media as established information.

Development and Use of a Mobile Texting App ‘Heptalk’: Its Efficacy in Patient Engagement in Viral Hepatitis B Care

  • Chul Hyun; 
  • Joseph McMenamin; 
  • Okhyun Ko; 
  • Soonsik Kim; 

ABSTRACT

Background:

Chronic hepatitis B virus (HBV) infection is a major cause of liver-related morbidity and mortality among Asian Americans in the U.S. population. Despite the available resources, a majority of HBV infected individuals are not able to access adequate health care owing to numerous barriers.

Objective:

This study was designed to assess the efficacy of a newly developed mobile texting app ‘heptalk’ to overcome these barriers and to help engage HBV infected and non-immune individuals to health access.

Methods:

A mobile texting app heptalk was employed for a two-way communication between patients and patient navigators (PNs). A total of 82 Korean-American participants who were either HBV infected or non-immune to HBV were enrolled for the study. After informed consent was obtained, both the frequency and themes of the texting messages were evaluated. The effects of these communications on the linkage to care (LTC) at the end of the six-month intervention period were analyzed and discussed.

Results:

On average, PNs sent and received 14 and 8 messages per participant, respectively, during the six-month period. The themes of the messages were similar with respect to the following four categories: finding providers, scheduling appointments with providers, health education, and financial issues. Of 82 participants, a total of 78 were linked to care within six months, a 95 % linkage rate.

Conclusions:

A mobile texting app heptalk may be employed as an effective and strategic tool to facilitate communicative interaction between patients and PNs or healthcare providers (HCPs), thereby improving patient engagement and healthcare access.


 Citation

Please cite as:

Hyun C, McMenamin J, Ko O, Kim S

Development and Use of a Mobile Texting App ‘Heptalk’: Its Efficacy in Patient Engagement in Viral Hepatitis B Care

JMIR Preprints. 19/06/2019:15098

DOI: 10.2196/preprints.15098

URL: https://preprints.jmir.org/preprint/15098

PMID: 32234704

PMCID: 7160703

Download PDF


Request queued. Please wait while the file is being generated. It may take some time.

© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.